HYFTNasdaq

MindWalk Holdings Corp.

Pharmaceutical Preparations · A1 · CIK 1715925

MindWalk Holdings Corp. transforms drug discovery with patented AI technology and integrated wet labs

+ Watch View on EDGAR ↗

$73M

Market cap

$1.43

Last close

-2.0%

-8.9%

140K

Volume

Price$1.43-28.1%· 1Y

Volume

Sep 4L $1.02 · H $2.78Jul 10

Revenue & earnings

RevenueNet incomeLoss

Fundamentals & quality

Trailing fundamentals · via Polygon & SEC

Rev growth YoY

0.0%

Trailing 12 months

Gross margin

55.3%

Gross profit / revenue

Net margin

-123.3%

Net income / revenue

ROE

-128.0%

Return on equity

ROIC

—

Return on invested capital

FCF yield

-6.9%

Free cash flow / mkt cap

P/E

—

Price / earnings

P/S

4.3

Price / sales

Similar companies

Comparable business profile · signals at a glance

DRUGBRIGHT MINDS BIOSCIENCES INC.$663.3M-0.5%LTRNLantern Pharma Inc.$50.7M+7.5%ABSIAbsci Corp$2.0B-7.6%CERTCertara, Inc.$1.1B-0.3%GANXGain Therapeutics, Inc.

Filings archive

Newest first · each with a one-line AI read · showing 10 of 223

Jun 12, 20266-K6-KMindWalk Holdings Corp. announced a press release on June 12, 2026. The filing does not contain financial results or details of the press release's content.Jun 10, 20266-K6-KMindWalk Holdings Corp. announced a press release on June 10, 2026. The filing does not contain financial results or a specific material event beyond the announcement of the press release.Jun 2, 20266-K6-KMindWalk Holdings Corp. announced a press release on June 2, 2026.